SEC Form 4 · accession 0001209191-17-062112
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Saira Ramasastry
Director
Period of report
Nov 17, 2017
Accepted (ET)
Nov 21, 2017 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 17, 2017 | M | 5,000 | $5.03 | A | 5,000 | D | |
| Common Stock | Nov 17, 2017 | S | 5,000 | $14.6678 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.03 | Nov 17, 2017 | M | 5,000 | D | — | Jun 20, 2022 | Common Stock | 5,000 | 9,450 | D |
Explanation of responses
- F1Option is fully vested and exercisable.